Elliott Dasenbrook, MD, Assistant Professor of Medicine and Pediatrics, LeRoy W Matthews Cystic Fibrosis Center, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine wrote the following editorial for BMJ.
“Cystic fibrosis and survival in patients with advanced lung disease ::
rhDNase slows progression, and is strongly recommended in treatment guidelines”
